Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
20.8%
% of CANC's 48 holdings also in SBIO
11.8%
% of SBIO's 90 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
ZAI LAB LTD. UNSPONSORED ADR | 3.7% | 3.3% | 3.3% |
 |
MERUS N.V. | 3.1% | 2.7% | 2.7% |
 |
IDEAYA BIOSCIENCES, INC. | 1.5% | 1.2% | 1.2% |
|
CG ONCOLOGY, INC. | 1.2% | 1.7% | 1.2% |
 |
IMMUNOCORE HOLDINGS PLC SPONSORED ADR | 0.7% | 1.2% | 0.7% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to SBIO
|
REVOLUTION MEDICINES, INC. | 5.4% |
|
ELI LILLY & CO | 5.3% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 5.2% |
|
BRISTOL-MYERS SQUIBB CO | 4.5% |
|
ASTRAZENECA PLC | 4.3% |
|
NOVARTIS AG | 4.2% |
|
BRIDGEBIO PHARMA, INC. | 4.1% |
|
EXELIXIS INC | 4.0% |
|
NUVALENT, INC. CLASS A | 3.8% |
 |
GENMAB A/S SPONSORED ADR | 3.1% |
CANC Underweight Relative to SBIO
 |
ALKERMES PLC | -4.5% |
|
AXSOME THERAPEUTICS, INC. | -4.5% |
|
PTC THERAPEUTICS INC | -3.6% |
|
AVIDITY BIOSCIENCES INC | -3.2% |
|
RHYTHM PHARMACEUTICALS, INC. | -3.0% |
|
AKERO THERAPEUTICS, INC. | -2.9% |
|
CRINETICS PHARMACEUTICALS INC | -2.7% |
|
PROTAGONIST THERAPEUTICS, INC. | -2.6% |
|
ACADIA PHARMACEUTICALS INC | -2.4% |
|
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -2.2% |